A Novel Effective and Safe Vaccine for Prevention of Marek's Disease Caused by Infection with a Very Virulent Plus (vv+) Marek's Disease Virus
- PMID: 33669421
- PMCID: PMC7920416
- DOI: 10.3390/vaccines9020159
A Novel Effective and Safe Vaccine for Prevention of Marek's Disease Caused by Infection with a Very Virulent Plus (vv+) Marek's Disease Virus
Abstract
Marek's disease virus (MDV) is a highly contagious alphaherpesvirus that causes rapid onset lymphoma in chickens. Marek's disease (MD) is effectively controlled using vaccination; however, MDV continues to break through vaccinal immunity, due to the emergence of highly virulent field strains. Earlier studies revealed that deletion of the meq gene from MDV resulted in an attenuated virus that protects against MD in chickens challenged with highly virulent field strains. However, the meq deleted virus retains the ability to induce significant lymphoid organ atrophy. In a different study, we found that the deletion of the vIL8 gene resulted in the loss of lymphoid organ atrophy in inoculated chickens. Here, we describe the generation of a recombinant MDV from which both meq and vIL8 genes were deleted. In vitro studies revealed that the meq and vIL8 double deletion virus replicated at levels similar to the parental very virulent plus (vv+) virus. In addition, in vivo studies showed that the double deletion mutant virus (686BAC-ΔMeqΔvIL8) conferred protection comparable to CVI988, a commercial vaccine strain, when challenged with a vv+ MDV virus, and significantly reduced lymphoid organ atrophy, when compared to meq null virus, in chickens. In conclusion, our study describes the development of a safe and effective vaccine candidate for prevention of MD in chickens.
Keywords: Marek’s disease virus; Meq; lymphoid organ atrophy; vIL8; vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7920416/bin/vaccines-09-00159-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7920416/bin/vaccines-09-00159-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7920416/bin/vaccines-09-00159-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7920416/bin/vaccines-09-00159-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7920416/bin/vaccines-09-00159-g005.gif)
Similar articles
-
Fully Attenuated meq and pp38 Double Gene Deletion Mutant Virus Confers Superior Immunological Protection against Highly Virulent Marek's Disease Virus Infection.Microbiol Spectr. 2022 Dec 21;10(6):e0287122. doi: 10.1128/spectrum.02871-22. Epub 2022 Nov 9. Microbiol Spectr. 2022. PMID: 36350141 Free PMC article.
-
Deletion of the Viral Thymidine Kinase in a Meq-Deleted Recombinant Marek's Disease Virus Reduces Lymphoid Atrophy but Is Less Protective.Microorganisms. 2021 Dec 22;10(1):7. doi: 10.3390/microorganisms10010007. Microorganisms. 2021. PMID: 35056456 Free PMC article.
-
Lorf9 deletion significantly eliminated lymphoid organ atrophy induced by meq-deleted very virulent Marek's disease virus.Vet Microbiol. 2019 Aug;235:164-169. doi: 10.1016/j.vetmic.2019.06.020. Epub 2019 Jul 2. Vet Microbiol. 2019. PMID: 31282374
-
Prevention of Marek's disease: a review.Cancer Res. 1976 Feb;36(2 pt 2):696-700. Cancer Res. 1976. PMID: 766959 Review.
-
Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.Vet Immunol Immunopathol. 2006 Jul 15;112(1-2):78-86. doi: 10.1016/j.vetimm.2006.03.014. Epub 2006 May 8. Vet Immunol Immunopathol. 2006. PMID: 16682084 Review.
Cited by
-
Fully Attenuated meq and pp38 Double Gene Deletion Mutant Virus Confers Superior Immunological Protection against Highly Virulent Marek's Disease Virus Infection.Microbiol Spectr. 2022 Dec 21;10(6):e0287122. doi: 10.1128/spectrum.02871-22. Epub 2022 Nov 9. Microbiol Spectr. 2022. PMID: 36350141 Free PMC article.
-
Deletion of the Viral Thymidine Kinase in a Meq-Deleted Recombinant Marek's Disease Virus Reduces Lymphoid Atrophy but Is Less Protective.Microorganisms. 2021 Dec 22;10(1):7. doi: 10.3390/microorganisms10010007. Microorganisms. 2021. PMID: 35056456 Free PMC article.
-
Methods for the Manipulation of Herpesvirus Genome and the Application to Marek's Disease Virus Research.Microorganisms. 2021 Jun 10;9(6):1260. doi: 10.3390/microorganisms9061260. Microorganisms. 2021. PMID: 34200544 Free PMC article. Review.
-
A Single Amino Acid at Residue 188 of the Hexon Protein Is Responsible for the Pathogenicity of the Emerging Novel Virus Fowl Adenovirus 4.J Virol. 2021 Aug 10;95(17):e0060321. doi: 10.1128/JVI.00603-21. Epub 2021 Aug 10. J Virol. 2021. PMID: 34133902 Free PMC article.
-
Latest Insights into Unique Open Reading Frames Encoded by Unique Long (UL) and Short (US) Regions of Marek's Disease Virus.Viruses. 2021 May 25;13(6):974. doi: 10.3390/v13060974. Viruses. 2021. PMID: 34070255 Free PMC article. Review.
References
-
- Calnek B.W. Pathogenesis of Marek’s disease virus infection. Curr Top. Microbiol. Immunol. 2001;255:25–55. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources